Chokshi Lab London (@chokshilab) 's Twitter Profile
Chokshi Lab London

@chokshilab

Our research interests focus on the #pathophysiology and #immunology of #ViralHepatitis, #AlcoholicLiverDisease #ALD and #LiverCancer, #Hepatology, #ChokshiLab

ID: 722370625252274176

calendar_today19-04-2016 10:25:52

1,1K Tweet

765 Followers

865 Following

Evangelos Triantafyllou (@triantafylloue_) 's Twitter Profile Photo

🎯JOB ALERT🚨| Research Assistant or Associate in Computational Immunology | We are seeking to recruit a scientist with immunology and bioinformatics (scRNA-seq) background. Join our team at Imperial College London |🧪🥼👉triantafylloulab.com Information: imperial.ac.uk/jobs/search-jo…

EASLnews (@easlnews) 's Twitter Profile Photo

Would you like to host an EASL School in 2026, in your European institution? Please share your ideas by completing and returning the application by Sunday, 3 November 2024 (23:59 CET). ℹ️ easl.eu/schools26 #LiverTwitter

Would you like to host an EASL School in 2026, in your European institution?

Please share your ideas by completing and returning the application by Sunday, 3 November 2024 (23:59 CET).

ℹ️ easl.eu/schools26

#LiverTwitter
The Roger Williams Institute of Liver Studies (@inst_of_liver) 's Twitter Profile Photo

‼️ #PostDoc Job Opportunity ‼️ 📣 Passionate about #mitochondria? Do you believe the best has yet to come for mitochondria-targeted therapies? 👩‍🔬🧪 Apply bellow to join our Mitochondrial Medicine for Liver Disease group! 🦠🔬 liver-research.org.uk/liver-foundati… #LiverTwitter

Ramon Bataller (@rabataller) 's Twitter Profile Photo

Conclusions of a statement of ALD EXPERTS on MetALD: 🔸"Met" should include >1 risk factor: alcohol itself favors metabolic syndrome. 🔸Alcohol thresholds need prospective studies including biomarkers. 🔸Trials testing therapies for MetALD are needed. t.ly/L2JWE

Conclusions of a statement of ALD EXPERTS on  MetALD:
🔸"Met" should include >1 risk factor: alcohol itself favors metabolic syndrome.
🔸Alcohol thresholds need prospective studies including biomarkers.
🔸Trials testing therapies for MetALD are needed.

t.ly/L2JWE
Dr Antonio Riva (@drantonioriva) 's Twitter Profile Photo

New immunological signatures linked to severity, stage, and potentially response to ursodeoxycholate in #PrimaryBiliaryCholangitis. #HVEM, #interferon #IFNλ3, #IFNγ, #GutBarrierPermeability PBC Foundation mdpi.com/1422-0067/26/2…

New immunological signatures linked to severity, stage, and potentially response to ursodeoxycholate in #PrimaryBiliaryCholangitis.

#HVEM, #interferon #IFNλ3, #IFNγ, #GutBarrierPermeability

<a href="/PBCFoundation/">PBC Foundation</a>

mdpi.com/1422-0067/26/2…
ElePalma (@drelepalma) 's Twitter Profile Photo

I was honoured to present at the SLD Summit, sharing insights into the fascinating world of mitochondria. ☺️A huge thank you to the organisers and attendees. 🤩I am excited for the future of research in this field and the upcoming studies with my MitoMed lab The Roger Williams Institute of Liver Studies!